dimethylmyleran has been researched along with Neoplasms in 3 studies
dimethylmyleran: RN given refers to cpd without isomeric designation
dimethylmyleran : A methanesulfonate ester that is hexane-2,5-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BIERMAN, HR | 1 |
| KELLY, KH | 1 |
| KNUDSON, AG | 1 |
| MAEKAWA, T | 1 |
| TIMMIS, GM | 2 |
| CLIFFORD, P | 1 |
| CLIFT, RA | 2 |
| KHAN, AG | 1 |
| Kanfer, EJ | 1 |
| Petersen, FB | 1 |
| Buckner, CD | 1 |
| Stewart, P | 1 |
| Storb, R | 1 |
| Hill, RS | 1 |
| Appelbaum, FR | 1 |
| Doney, KC | 1 |
| Shulman, HM | 1 |
3 other studies available for dimethylmyleran and Neoplasms
| Article | Year |
|---|---|
The influence of 1, 4-dimethylsulfonoxy-1, 4-dimethylbutane (CB 2348, dimethyl myleran) in neoplastic disease.
Topics: Busulfan; Leadership; Neoplasms | 1958 |
DIMETHYL MYLERAN THERAPY COMBINED WITH ABDOMINAL AORTIC OCCLUSION.
Topics: Adolescent; Alopecia; Aorta; Aorta, Abdominal; Busulfan; Chemotherapy, Cancer, Regional Perfusion; D | 1964 |
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Drug Eva | 1987 |